| |
Overview
HeadlinesNo recent Headlines for this stock. Business Background Avrobio Inc is a clinical stage gene therapy company. It is engaged in the development of potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose.
| |